
The Omicron variant could prompt a reshuffling of the way doctors treat COVID infections in the United States, and antiviral pills will likely lead the way in that redoubled effort, Harvard experts say. New antiviral pills developed by Merck and Pfizer are expected to remain effective against the Omicron variant, mostly because they interfere with… read on > read on >